无药物体外激活卵泡与新鲜组织自体移植治疗原发性卵巢功能不全
这项前瞻性观察队列研究在14例原发性卵巢功能不全(POI)患者中实施无药物体外激活卵泡(drug-free IVA)联合新鲜卵巢组织自体移植,术后立即启动人绝经期促性腺激素(HMG)。7例检测到卵泡发育,5例成功获卵,5例患者完成6次胚胎移植,获得4例妊娠。结论认为drug-free IVA可能为POI患者的有用治疗选择,并带来成功的IVF结局。
要点
- 无药物IVA联合新鲜组织自体移植在部分POI患者中可诱导卵泡发育。
- 14例中7例检测到卵泡发育,5例成功获卵。
- 5例患者6次胚胎移植后获得4例妊娠。
核心结论
- 无药物体外激活卵泡(drug-free IVA)可能成为POI患者的有用治疗选择,并带来成功的IVF结局。
研究设计与样本
- 前瞻性观察队列研究,在三级大学医院开展。
- 纳入14例POI女性,中位年龄33岁(29-36岁),中位闭经时长1.5年(1-11年)。
- 中位FSH为69.2 mIU/ml(36.9-82.8 mIU/ml),抗苗勒管激素为0.02 ng/ml(0.01-0.1 ng/ml)。
- 手术包括腹腔镜下切除卵巢皮质、组织碎片化及自体移植,术后立即启动人绝经期促性腺激素(HMG)。
主要发现
- 14例患者中7例检测到卵泡发育。
- 5例女性成功获卵。
- 6例女性在10个周期中给予HCG。
- 5例女性完成6次胚胎移植,获得4例妊娠。
- 临床妊娠率为7次获卵中4次、6次胚胎移植中4次。
临床怎么用
- 对于POI患者,可考虑无药物IVA联合新鲜组织自体移植作为辅助生殖治疗选择。
- 术后需立即启动HMG以支持卵泡发育。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Could in-vitro action of follicles and fresh tissue autotransplantation without tissue culture (drug-free IVA) be useful in patients with primary ovarian insufficiency (POI)? DESIGN: Prospective observational cohort study in a tertiary university hospital. Drug-Free IVA was carried out in 14 women with POI with a median age of 33 years (29-36 years), median length of amenorrhoea of 1.5 years (1-11 years), median FSH levels 69.2 mIU/ml (36.9-82.8 mIU/ml) and anti-Müllerian hormone of 0.02 ng/ml (0.01-0.1 ng/ml). The surgical procedure included laparoscopic removal of ovarian cortex, fragmentation of tissue and autografting. Human menopausal gonadotrophin (HMG) was started immediately after surgery. RESULTS: Follicle development was detected in seven out of the 14 patients, and five women achieved successful oocyte retrieval. In six women, HCG was administered in 10 cycles. Six embryo transfers were carried out in five women resulting in four pregnancies; a clinical pregnancy rate of four in seven oocyte retrievals and four in six embryo transfers. CONCLUSIONS: Drug-free IVA could be a useful therapeutic option for patients with POI, leading to successful IVF outcomes.
引用
- Ferreri J, Fàbregues F, Calafell JM, et al. Drug-free in-vitro activation of follicles and fresh tissue autotransplantation as a therapeutic option in patients with primary ovarian insufficiency. Reprod Biomed Online. 2019. PMID: 31956062. doi:10.1016/j.rbmo.2019.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。